Boyan Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Boyan Li has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Timothy J. Mitchison
Department of Systems Biology, Harvard Medical School, Boston, MA, USA
2 shared publications Bert M. Verheijen
Department of Systems Biology, Harvard Medical School, Boston, USA
1 shared publicationChristine M. Field
Department of Systems Biology, Harvard Medical School, Boston, USA
1 shared publication- Emrah Şimşek
Department of Biomedical Engineering, Duke University
1 shared publication - Helena R. Ma
Department of Biomedical Engineering, Duke University, Durham, USA
1 shared publication - Joao A. Paulo
Department of Cell Biology, Harvard Medical School, Boston, MA, USA
1 shared publication
Latest Publications
- Open Access
- 19 May 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (21)
Rebinding drives cellular retention of small-molecule drugs with abundant targets
Many small-molecule antitumor drugs are administered far less frequently than would be predicted from their plasma half-lives, in part because their efficacy is driven by prolonged retention within tumors. Drug retention can be caused by nonspecific protein binding, low membrane permeability, sequestration in acidic compartments, slow target dissociation, and rebinding to empty target sites, but the field has lacked a quantitative framework and preclinical assays for discriminating these mechanisms and predicting retention in vivo. We developed a theoretical framework and a simple two-drug assay for quantifying retention mechanisms in cell-based models. Application to 13 drugs with 8 distinct intracellular targets revealed diverse retention mechanisms. Rebinding emerged as a potent driver of retention whose magnitude was predicted by the target-to-affinity ratio ([Target]/ K d ). Rebinding slows the washout rates of important drugs such as taxanes and rapamycin by 100-fold or more. It also explains the need for high loading concentrations. Our approach bridges a critical gap in pharmacology modeling and provides practical tools to guide the design of intermittent dosing regimens.
- 19 May 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (21)
Open AccessRebinding drives cellular retention of small-molecule drugs with abundant targets
Many small-molecule antitumor drugs are administered far less frequently than would be predicted from their plasma half-lives, in part because their efficacy is driven by prolonged retention within tumors. Drug retention can be caused by nonspecific protein binding, low membrane permeability, sequestration in acidic compartments, slow target dissociation, and rebinding to empty target sites, but the field has lacked a quantitative framework and preclinical assays for discriminating these mechanisms and predicting retention in vivo. We developed a theoretical framework and a simple two-drug assay for quantifying retention mechanisms in cell-based models. Application to 13 drugs with 8 distinct intracellular targets revealed diverse retention mechanisms. Rebinding emerged as a potent driver of retention whose magnitude was predicted by the target-to-affinity ratio ([Target]/ K d ). Rebinding slows the washout rates of important drugs such as taxanes and rapamycin by 100-fold or more. It also explains the need for high loading concentrations. Our approach bridges a critical gap in pharmacology modeling and provides practical tools to guide the design of intermittent dosing regimens.
- Open Access
- 22 August 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-24
Episodic transport of protein aggregates achieves a positive size selectivity in aggresome formation
Eukaryotic cells direct toxic misfolded proteins to various quality control pathways based on their chemical properties and aggregation status. Aggregated proteins are targeted to selective autophagy or specifically sequestered into the “aggresome”, a perinuclear inclusion at the microtubule-organizing center (MTOC). However, the mechanism for selective aggresome recruitment remains unclear. To investigate this process, here we reconstitute MTOC-directed aggregate transport in Xenopus laevis egg extract using AgDD, a chemically inducible aggregation system. High-resolution single-particle tracking reveals that dynein-mediated aggregate transport is highly episodic, with average velocity positively correlating with aggregate size. Mechanistic modeling suggests that recurrent formation of the dynein transport complex biases larger aggregates towards active transport, compensating for the slowdown due to viscosity. Both episodic transport and positive size selectivity are conferred by aggresome-specific dynein adapters. Coupling an aggresome adapter to polystyrene beads recapitulates positive size selectivity in transport, while recruiting conventional dynein adapters to protein aggregates perturbs aggresome formation and reverses the size selectivity.
- 22 August 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-24
Open AccessEpisodic transport of protein aggregates achieves a positive size selectivity in aggresome formation
Eukaryotic cells direct toxic misfolded proteins to various quality control pathways based on their chemical properties and aggregation status. Aggregated proteins are targeted to selective autophagy or specifically sequestered into the “aggresome”, a perinuclear inclusion at the microtubule-organizing center (MTOC). However, the mechanism for selective aggresome recruitment remains unclear. To investigate this process, here we reconstitute MTOC-directed aggregate transport in Xenopus laevis egg extract using AgDD, a chemically inducible aggregation system. High-resolution single-particle tracking reveals that dynein-mediated aggregate transport is highly episodic, with average velocity positively correlating with aggregate size. Mechanistic modeling suggests that recurrent formation of the dynein transport complex biases larger aggregates towards active transport, compensating for the slowdown due to viscosity. Both episodic transport and positive size selectivity are conferred by aggresome-specific dynein adapters. Coupling an aggresome adapter to polystyrene beads recapitulates positive size selectivity in transport, while recruiting conventional dynein adapters to protein aggregates perturbs aggresome formation and reverses the size selectivity.
- Open Access
Mapping single-cell responses to population-level dynamics during antibiotic treatment
Treatment of sensitive bacteria with beta-lactam antibiotics often leads to two salient population-level features: a transient increase in total population biomass before a subsequent decline, and a linear correlation between growth and killing rates. However, it remains unclear how these population-level responses emerge from collective single-cell responses. During beta-lactam treatment, it is well recognized that individual cells often exhibit varying degrees of filamentation before lysis. We show that the probability of cell lysis increases with the extent of filamentation and that this dependence is characterized by unique parameters that are specific to bacterial strain, antibiotic dose, and growth condition. Modeling demonstrates how the single-cell lysis probabilities can give rise to population-level biomass dynamics, which were experimentally validated. This mapping provides insights into how the population biomass time-kill curve emerges from single cells and allows the representation of both single-and population-level responses with universal parameters.
Open AccessMapping single-cell responses to population-level dynamics during antibiotic treatment
Treatment of sensitive bacteria with beta-lactam antibiotics often leads to two salient population-level features: a transient increase in total population biomass before a subsequent decline, and a linear correlation between growth and killing rates. However, it remains unclear how these population-level responses emerge from collective single-cell responses. During beta-lactam treatment, it is well recognized that individual cells often exhibit varying degrees of filamentation before lysis. We show that the probability of cell lysis increases with the extent of filamentation and that this dependence is characterized by unique parameters that are specific to bacterial strain, antibiotic dose, and growth condition. Modeling demonstrates how the single-cell lysis probabilities can give rise to population-level biomass dynamics, which were experimentally validated. This mapping provides insights into how the population biomass time-kill curve emerges from single cells and allows the representation of both single-and population-level responses with universal parameters.